New oral combo aims to control Tough-to-Treat blood cancer
NCT ID NCT04746235
Summary
This study is testing whether taking two oral medications together—venetoclax and ASTX727—can help control acute myeloid leukemia (AML), a type of blood cancer. It is for adults whose AML has come back or hasn't responded to prior treatment, or for older or less-fit adults newly diagnosed with AML who cannot tolerate strong chemotherapy. The goal is to see if this combination can reduce cancer cells and control the disease, potentially allowing some patients to proceed to a stem cell transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.